EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023, and October 31, 2024, to join a securities fraud lawsuit. The deadline for lead plaintiff applications is March 25, 2025.
February 28, 2025 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a securities fraud lawsuit, and investors who purchased shares between Dec 12, 2023, and Oct 31, 2024, can join. This legal action may impact the stock price negatively in the short term.
The announcement of a securities fraud lawsuit against ESSA Pharma is likely to create uncertainty and negative sentiment among investors, potentially leading to a decline in the stock price. The legal proceedings could also result in financial liabilities for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100